MAKING THE PRESS
The physicians, staff, and patients at Mary Crowley Cancer Research are proud to have collaborated with BioVex to help develop and lead the pivotal Phase II trial of the first-of-its-kind cancer-specific, immune-enhancing herpes virus for patients with melanoma, which was just approved by the FDA. Read Full Story Here.
Mary Crowley Cancer Research “teams up” with Dallas Stars Foundation to fight cancer. Read Full Story Here.
Mary Crowley Cancer Research hosted the “Celebrate Life Sip & Shop” on Wednesday, October 21, 2015. Read Full Story Here.
The First Baptist Academy of Dallas paid tribute to Julie Shoemake, one of their Lower School principals, on October 9, 2015. Read Full Story Here.
Dr. John Nemunaitis, Executive Medical Director at Mary Crowley, is scheduled to present at World Conference on Lung Cancer, September 8, 2015. Read Full Story Here.
